A Double Blind Controlled Trial of N‐(3′, 4′‐Dimethoxycinnamoyl) Anthranilic Acid on Children with Bronchial Asthma
- 1 August 1979
- Vol. 34 (4) , 213-219
- https://doi.org/10.1111/j.1398-9995.1979.tb01701.x
Abstract
A double-blind controlled trial of N-(3'',4''-dimethoxycinnamoyl) anthranilic acid (N-5'') was carried out for treating children with bronchial asthma to determine its efficacy and safety. The drug was significantly more effective in the N10 and N5 groups than in the N0 group. Adverse reactions appeared only in 1 patient in the N10 group who complained of slight anorexia while another patient in the N0 group reported moderate diarrhea. There was no indication of abnormality in further laboratory investigations. This drug is useful for the treatment of children with bronchial asthma.Keywords
This publication has 1 reference indexed in Scilit:
- Inhibition of hypersensitivity reactions by a new drug, N(3′,4′-dimethoxycinnamoyl) anthranilic acid (N-5′)Journal of Allergy and Clinical Immunology, 1976